(12-192) INDUC-DOAC trial: Ischemic stroke and venous thromboembolism (VTE) incidence with Pgp/CYP INDUCtion with concomitant use of Direct Oral AntiCoagulant apixaban, rivaroxaban or dabigatran.
Wednesday, December 6, 2023
2:00 PM - 3:00 PM
Location: Hall E, Lower Level
Co-Author(s): Amneh Alzatout, Taha Alhayani, Joe Schum, Corey Wirth
